Consistently, our study demonstrated that hepatocyte-derived CTGF increased the phosphorylation of p38 and p65 and promoted HSCs’ activation through EGFR, thereby contributing to liver fibrosis. The gene discussed is CCN2; the disease is Hepatic fibrosis.